Coagulation defects in neonates during cardiopulmonary bypass
- PMID: 1510523
- DOI: 10.1016/0003-4975(92)90451-9
Coagulation defects in neonates during cardiopulmonary bypass
Abstract
We examined components of the coagulation system in 30 neonates (age, 1 to 30 days) undergoing deep hypothermic cardiopulmonary bypass (CPB). A coagulation profile consisting of activated clotting time; prothrombin time; partial thromboplastin time; factors II, V, VII, VIII, IX, X, and I (fibrinogen); antithrombin III; platelet count; and heparin levels was evaluated before bypass, at three intervals during bypass (1 minute after initiation of bypass, stable hypothermic CPB, warm CPB), after weaning from CPB and administration of protamine, and 2 to 3 hours after skin closure. The initiation of CPB resulted in a 50% decrease in circulating coagulation factors and antithrombin III levels. Platelet counts were reduced by 70% with CPB initiation. Neither deep hypothermic temperatures nor prolonged exposure to extracorporeal surfaces had any additional effect on the coagulation profiles. This suggests that the coagulation system of a neonate undergoing CPB is profoundly and globally effected by hemodilution. We believe that treatment of post-CPB coagulopathy in neonates must address these global deficits.
Comment in
-
Coagulation defects in neonates during cardiopulmonary bypass.Ann Thorac Surg. 1993 May;55(5):1283-4. doi: 10.1016/0003-4975(93)90073-q. Ann Thorac Surg. 1993. PMID: 8338580 No abstract available.
Similar articles
-
Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass.Thromb Haemost. 1997 Feb;77(2):270-7. Thromb Haemost. 1997. PMID: 9157580
-
Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.Thorac Cardiovasc Surg. 2015 Aug;63(5):397-403. doi: 10.1055/s-0035-1554998. Epub 2015 Jun 29. Thorac Cardiovasc Surg. 2015. PMID: 26121380
-
Hemostasis changes during cardiopulmonary bypass surgery.Semin Thromb Hemost. 1985 Jul;11(3):281-92. doi: 10.1055/s-2007-1004382. Semin Thromb Hemost. 1985. PMID: 4048952
-
Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.J Cardiothorac Vasc Anesth. 1999 Aug;13(4 Suppl 1):18-29; discussion 36-7. J Cardiothorac Vasc Anesth. 1999. PMID: 10468245 Review.
-
Hemostatic defects induced by cardiopulmonary bypass.Vasc Surg. 1975 Sep-Oct;9(4):228-43. doi: 10.1177/153857447500900407. Vasc Surg. 1975. PMID: 1106031 Review. No abstract available.
Cited by
-
Fresh frozen plasma in pump priming for congenital heart surgery: evaluation of effects on postoperative coagulation profiles using a fibrinogen assay and rotational thromboelastometry.Yonsei Med J. 2013 May 1;54(3):752-62. doi: 10.3349/ymj.2013.54.3.752. Yonsei Med J. 2013. PMID: 23549826 Free PMC article. Clinical Trial.
-
Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery?Interact Cardiovasc Thorac Surg. 2012 Oct;15(4):690-4. doi: 10.1093/icvts/ivs309. Epub 2012 Jul 18. Interact Cardiovasc Thorac Surg. 2012. PMID: 22811512 Free PMC article. Review.
-
Safety of aprotinin in congenital heart operations: results from a large multicenter database.Ann Thorac Surg. 2010 Jul;90(1):14-21. doi: 10.1016/j.athoracsur.2010.02.073. Ann Thorac Surg. 2010. PMID: 20609740 Free PMC article.
-
Extracorporeal Life Support for Pediatric Heart Failure.Front Pediatr. 2016 Oct 20;4:115. doi: 10.3389/fped.2016.00115. eCollection 2016. Front Pediatr. 2016. PMID: 27812522 Free PMC article. Review.
-
A Randomized Pilot Trial Assessing the Role of Human Fibrinogen Concentrate in Decreasing Cryoprecipitate Use and Blood Loss in Infants Undergoing Cardiopulmonary Bypass.Pediatr Cardiol. 2022 Oct;43(7):1444-1454. doi: 10.1007/s00246-022-02866-4. Epub 2022 Mar 19. Pediatr Cardiol. 2022. PMID: 35305111 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical